Person: Iglesias Peinado, Irene
Loading...
First Name
Irene
Last Name
Iglesias Peinado
Affiliation
Universidad Complutense de Madrid
Faculty / Institute
Farmacia
Department
Farmacología, Farmacognosia y Botánica
Area
Farmacología
Identifiers
6 results
Search Results
Now showing 1 - 6 of 6
- Project number: 249
Item Flipped Learning y Web App de Plantas Medicinales Nuevas estrategias educativas aplicadas al ámbito de la enseñanza en la asignatura de Farmacognosia y Fitoterapia(2017) Gómez-Serranillos Cuadrado, María Pilar; González Burgos, Elena María; Fernández Moriano, Carlos; Iglesias Peinado, Irene; Gavilán García, Rosario Gloria; Garcia Broncano, Rosario - Project number: 72
Item Diseño e implantación de un sistema de seguimiento de calidad mediante la utilización de plataformas online(2019) Iglesias Peinado, Irene; Córdoba Díaz, Manuel; Elorza Barroeta, Begoña; Escario García-Trevijano, José Antonio; Gómez-Serranillos Cuadrado, María Pilar; Lozano Fernández, Rafael; Román Zaragoza, Jesús; González Villa, Ana María; Rayego Sánchez, Gema Item The Pharmacological Activity of Camellia sinensis (L.) Kuntze on Metabolic and Endocrine Disorders: A Systematic Review(Biomolecules, 2020) Sánchez-Paniagua López, Marta; González Burgos, Elena María; Iglesias Peinado, Irene; Lozano Fernández, Rafael; Gómez-Serranillos Cuadrado, María PilarTea made from Camellia sinensis leaves is one of the most consumed beverages worldwide. This systematic review aims to update Camellia sinensis pharmacological activity on metabolic and endocrine disorders. Inclusion criteria were preclinical and clinical studies of tea extracts and isolated compounds on osteoporosis, hypertension, diabetes, metabolic syndrome, hypercholesterolemia, and obesity written in English between 2014 and 2019 and published in Pubmed, Science Direct, and Scopus. From a total of 1384 studies, 80 reports met inclusion criteria. Most papers were published in 2015 (29.3%) and 2017 (20.6%), conducted in China (28.75%), US (12.5%), and South Korea (10%) and carried out with extracts (67.5%, especially green tea) and isolated compounds (41.25%, especially epigallocatechin gallate). Most pharmacological studies were in vitro and in vivo studies focused on diabetes and obesity. Clinical trials, although they have demonstrated promising results, are very limited. Future research should be aimed at providing more clinical evidence on less studied pathologies such as osteoporosis, hypertension, and metabolic syndrome. Given the close relationship among all endocrine disorders, it would be of interest to find a standard dose of tea or their bioactive constituents that would be beneficial for all of them.Item Current uses and knowledge of medicinal plants in the Autonomous Community of Madrid (Spain): a descriptive cross-sectional study(2020) Sánchez Gómez-Serranillos, Marta; González Burgos, Elena María; Iglesias Peinado, Irene; Lozano Fernández, Rafael; Gómez-Serranillos Cuadrado, María PilarBackground The usage of medicinal plants as a key component of complementary and alternative medicine, has acquired renewed interest in developed countries. The current situation of medicinal plants in Spain is very limited. This paper provides new insights and greater knowledge about current trends and consumption patterns of medicinal plants in the Autonomous Community of Madrid (Spain) for health benefits. Methods A descriptive cross-sectional study was designed for a population-based survey on medicinal plants. The data were collected (May 2018 to May 2019) using semi-structured face-to-face interviews in independent pharmacies, hospital centers and primary care health centers in the Autonomous Community of Madrid. The survey had 18 multiple choice and open-ended questions. Quantitative indices were calculated: Fidelity Level (FL), Use Value (UV) and Informants Consensus Factor (ICF). Chi-square test was used for data analysis. Results Five hundred forty-three people were interviewed. The majority of the participants (89.6%) have used medicinal plants to treat health disorders in the past 12 months, mainly for digestive problems, sleep disorders and central nervous system diseases. A total of 78 plants were recorded, being Matricaria recutita, Valeriana officinalis, Tilia spp. and Aloe vera the most used. The highest UV was found for Mentha pulegium (UV 0.130) followed by Aloe vera (UV 0.097) and Vaccinium macrocarpon. (UV 0.080). The highest FL values were for Eucalyptus spp. (FL 90.47%) for respiratory conditions and, Matricaria recutita (85.55%) and Mentha pulegium (84.09%) for digestive problems. The highest ICF corresponded to metabolism and depression (ICF = 1), pain (ICF = 0.97), insomnia (ICF = 0.96) and anxiety (ICF = 0.95). Participants mostly acquired herbal medicines from pharmacies, herbal shops and supermarkets. Some side effects (tachycardia, dizziness and gastrointestinal symptoms) and potential interactions medicinal plants-drugs (V. officinalis and benzodiazepines) were reported. Conclusion Many inhabitants of the Autonomous Community of Madrid currently use herbal products to treat minor health problems. The most common consumer pattern are young women between 18 and 44 years of age with higher education. In order to confirm the pattern, further research should be focused to investigate current uses of medicinal plants in other Spanish regions.Item Pharmacological Update Properties of Aloe Vera and its Major Active Constituents(Molecules, 2020) Sánchez Gómez-Serranillos, Marta; González Burgos, Elena María; Iglesias Peinado, Irene; Gómez-Serranillos Cuadrado, María PilarAloe vera has been traditionally used to treat skin injuries (burns, cuts, insect bites, and eczemas) and digestive problems because its anti-inflammatory, antimicrobial, and wound healing properties. Research on this medicinal plant has been aimed at validating traditional uses and deepening the mechanism of action, identifying the compounds responsible for these activities. The most investigated active compounds are aloe-emodin, aloin, aloesin, emodin, and acemannan. Likewise, new actions have been investigated for Aloe vera and its active compounds. This review provides an overview of current pharmacological studies (in vitro, in vivo, and clinical trials), written in English during the last six years (2014–2019). In particular, new pharmacological data research has shown that most studies refer to anti-cancer action, skin and digestive protective activity, and antimicrobial properties. Most recent works are in vitro and in vivo. Clinical trials have been conducted just with Aloe vera, but not with isolated compounds; therefore, it would be interesting to study the clinical effect of relevant metabolites in different human conditions and pathologies. The promising results of these studies in basic research encourage a greater number of clinical trials to test the clinical application of Aloe vera and its main compounds, particularly on bone protection, cancer, and diabetes.- Project number: 9
Item Diseño de un sistema de información y gestión documental adaptado a normas ISO y AUDIT(2020) Iglesias Peinado, Irene; Córdoba Díaz, Manuel; Elorza Barroeta, Begoña; Escario García-Trevijano, José Antonio; Gómez-Serranillos Cuadrado, María Pilar; Lozano Fernández, Rafael; Román Zaragoza, Jesús; González Villa, Ana María; Rayego Sánchez, Gema; Valdés González, José Antonio